SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-101116
Filing Date
2021-08-06
Accepted
2021-08-06 08:31:19
Documents
46
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210630x10q.htm   iXBRL 10-Q 1324306
2 EXHIBIT 31.1 tmb-20210630xex31d1.htm EX-31.1 18612
3 EXHIBIT 31.2 tmb-20210630xex31d2.htm EX-31.2 16371
4 EXHIBIT 32.1 tmb-20210630xex32d1.htm EX-32.1 7827
5 EXHIBIT 32.2 tmb-20210630xex32d2.htm EX-32.2 7636
  Complete submission text file 0001104659-21-101116.txt   4408216

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210630.xsd EX-101.SCH 32774
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210630_lab.xml EX-101.LAB 246984
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210630_pre.xml EX-101.PRE 222017
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmb-20210630_cal.xml EX-101.CAL 21563
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210630_def.xml EX-101.DEF 137249
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210630x10q_htm.xml XML 631417
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 211150919
SIC: 2834 Pharmaceutical Preparations